228 related articles for article (PubMed ID: 34115519)
1. Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective.
Rahman SMK; Uyama T; Hussain Z; Ueda N
Annu Rev Nutr; 2021 Oct; 41():177-202. PubMed ID: 34115519
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and related
Tsuboi K; Uyama T; Okamoto Y; Ueda N
Inflamm Regen; 2018; 38():28. PubMed ID: 30288203
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids measurement in human saliva as potential biomarker of obesity.
Matias I; Gatta-Cherifi B; Tabarin A; Clark S; Leste-Lasserre T; Marsicano G; Piazza PV; Cota D
PLoS One; 2012; 7(7):e42399. PubMed ID: 22860123
[TBL] [Abstract][Full Text] [Related]
4. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine.
Artmann A; Petersen G; Hellgren LI; Boberg J; Skonberg C; Nellemann C; Hansen SH; Hansen HS
Biochim Biophys Acta; 2008 Apr; 1781(4):200-12. PubMed ID: 18316044
[TBL] [Abstract][Full Text] [Related]
5. Classical endocannabinoid-like compounds and their regulation by nutrients.
Kleberg K; Hassing HA; Hansen HS
Biofactors; 2014; 40(4):363-72. PubMed ID: 24677570
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids and nutrition.
Hansen HS; Artmann A
J Neuroendocrinol; 2008 May; 20 Suppl 1():94-9. PubMed ID: 18426507
[TBL] [Abstract][Full Text] [Related]
7. Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review.
Laleh P; Yaser K; Alireza O
J Cell Physiol; 2019 Jun; 234(6):7893-7902. PubMed ID: 30537148
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.
Ueda N; Tsuboi K; Uyama T
FEBS J; 2013 May; 280(9):1874-94. PubMed ID: 23425575
[TBL] [Abstract][Full Text] [Related]
9. Role of endocannabinoids and their analogues in obesity and eating disorders.
Gaetani S; Kaye WH; Cuomo V; Piomelli D
Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
Tutunchi H; Saghafi-Asl M; Ostadrahimi A
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.
Iannotti FA; Di Marzo V; Petrosino S
Prog Lipid Res; 2016 Apr; 62():107-28. PubMed ID: 26965148
[TBL] [Abstract][Full Text] [Related]
13. Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans.
Fuss J; Bindila L; Wiedemann K; Auer MK; Briken P; Biedermann SV
J Sex Med; 2017 Nov; 14(11):1372-1379. PubMed ID: 29110806
[TBL] [Abstract][Full Text] [Related]
14. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms.
Kaczocha M; Glaser ST; Maher T; Clavin B; Hamilton J; O'Rourke J; Rebecchi M; Puopolo M; Owada Y; Thanos PK
Mol Pain; 2015 Aug; 11():52. PubMed ID: 26311517
[TBL] [Abstract][Full Text] [Related]
16. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players.
Lambert DM; Muccioli GG
Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):735-44. PubMed ID: 18089956
[TBL] [Abstract][Full Text] [Related]
18. Oleic acid-derived oleoylethanolamide: A nutritional science perspective.
Bowen KJ; Kris-Etherton PM; Shearer GC; West SG; Reddivari L; Jones PJH
Prog Lipid Res; 2017 Jul; 67():1-15. PubMed ID: 28389247
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system in the adipose organ.
Jung KM; Lin L; Piomelli D
Rev Endocr Metab Disord; 2022 Feb; 23(1):51-60. PubMed ID: 33387286
[TBL] [Abstract][Full Text] [Related]
20. A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner.
Ramírez-López MT; Vázquez M; Lomazzo E; Hofmann C; Blanco RN; Alén F; Antón M; Decara J; Arco R; Orio L; Suárez J; Lutz B; Gómez de Heras R; Bindila L; Rodríguez de Fonseca F
PLoS One; 2017; 12(3):e0174307. PubMed ID: 28346523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
